KCM
NVO

Key Capital Management’s Novo Nordisk NVO Stock Holding History

Key Capital Management’s Portfolio NVO Stock Details NVO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$863 Sell
18
-24
-57% -$1.03K ﹤0.01% 668
2026
Q1 		$1.54K Buy
42
+24
+133% +$1.14K ﹤0.01% 570
2025
Q4 		$916 Buy
+18
New +$920 ﹤0.01% 443

Other funds holding NVO

Fisher Asset Management
Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return
EHC
Everett Harris & Co Los Angeles, California $8.14B AUM 14.79% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
SRIM
Saratoga Research & Investment Management Saratoga, California $1.83B AUM 18.41% 1-Year Est. Return
MG
Markel Group Glen Allen, Virginia $13.1B AUM 15.62% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
OAM
Oppenheimer Asset Management New York $9.63B AUM 30.32% 1-Year Est. Return
Truist Financial
Truist Financial Charlotte, North Carolina $83.7B AUM 27.22% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
SAM
Simplify Asset Management Las Vegas, Nevada $7.19B AUM 6.88% 1-Year Est. Return

Key Capital Management's NVO Position: Q2 2026 in Review

Key Capital Management reduced its Novo Nordisk (NVO) stake by 57% in Q2 2026, selling an estimated $1.03K and leaving 18 shares worth $863. The position accounts for ﹤0.01% of the portfolio, ranked #668.

Key Capital Management first reported a position in NVO in Q4 2025 and has held it in 3 quarters since. The position peaked at $1.54K in Q1 2026. 756 funds tracked by Wall St. Rank hold NVO as of Q2 2026.

  • Key Capital Management held 18 shares of Novo Nordisk worth $863 as of Q2 2026.
  • Key Capital Management sold 24 Novo Nordisk shares in Q2 2026, an estimated $1.03K.
  • Novo Nordisk made up ﹤0.01% of Key Capital Management's portfolio in Q2 2026, its #668 holding.
  • Key Capital Management first reported a position in Novo Nordisk in Q4 2025 and has held it in 3 quarters since.
  • Key Capital Management's Novo Nordisk position peaked at $1.54K in Q1 2026.
  • 756 funds tracked by Wall St. Rank held Novo Nordisk as of Q2 2026.

Based on Key Capital Management's 13F filing for Q2 2026, filed 28 Jul 2026.